Company / R&D per Share
Bio-Techne R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.63
FY2025
5-year range
$0.45 / $1.67
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#84 of 108
Health Care
What the data says
Bio-Techne's r&d per share of $0.63 is lower than 78% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 10 years, ranging from $0.45 in FY2023 to $1.72 in FY2020.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of -18.2%.
Improved from $0.45 to $0.63 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -27.8%
- 5-Year CAGR
- -18.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 108This company $0.63 Sector average $2.07
▼
-69.6% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 2.6% year-over-year.
- Ranks #84 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | +2.6% |
| FY2024 | $0.61 | +36.0% |
| FY2023 | $0.45 | -73.1% |
| FY2022 | $1.67 | +3.1% |
| FY2021 | $1.62 | -5.6% |
| FY2020 | $1.72 | +3.6% |
| FY2019 | $1.66 | +14.1% |
| FY2018 | $1.45 | +1.2% |
| FY2017 | $1.44 | +18.1% |
| FY2016 | $1.22 | +10.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026